Trial Profile
Randomized Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied Tazarotene Lotion in Comparison With Tazorac Cream in Subjects With Moderate to Severe Acne Vulgaris Under Maximal Use Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Tazarotene (Primary) ; Tazarotene
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Bausch Health Companies; Valeant Pharmaceuticals International
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 24 Apr 2017 Status changed from recruiting to completed.
- 04 Nov 2016 New trial record